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Abstract
Background: In patients with idiopathic normal pressure hydrocephalus (iNPH) responding to shunt surgery, we
have consistently found elevated intracranial pressure (ICP) wave amplitudes during diagnostic ICP monitoring prior
to surgery. It remains unknown why ICP wave amplitudes are increased in these patients. Since iNPH is
accompanied by a high incidence of vascular co-morbidity, a possible explanation is that there is reduced vascular
compliance accompanied by elevated arterial blood pressure (ABP) wave amplitudes and even altered cardiac
output (CO). To investigate this possibility, the present study was undertaken to continuously monitor CO to
determine if it is correlated to ABP and ICP wave amplitudes and the outcome of shunting in iNPH patients. It was
specifically addressed whether the increased ICP wave amplitudes seen in iNPH shunt responders were
accompanied by elevated CO and/or ABP wave amplitude levels.
Methods: Prospective iNPH patients (29) were clinically graded using an NPH grading scale. Continuous overnight
minimally-invasive monitoring of CO and ABP was done simultaneously with ICP monitoring; the CO, ABP, and ICP
parameters were parsed into 6-second time windows. Patients were assessed for shunt surgery on clinical grade,
Evan’s index, and ICP wave amplitude. Follow-up clinical grading was performed 12 months after surgery.
Results: ICP wave amplitudes but not CO or ABP wave amplitude, showed good correlation with the response to shunt
treatment. The patients with high ICP wave amplitude did not have accompanying high levels of CO or ABP wave
amplitude. Correlation analysis between CO and ICP wave amplitudes in individual patients showed different profiles
[significantly positive in 10 (35%) and significantly negative in 16 (55%) of 29 recordings]. This depended on whether there
was also a correlation between ABP and ICP wave amplitudes and on the average level of ICP wave amplitude.
Conclusions: These results gave no evidence that the increased levels of ICP wave amplitudes seen in iNPH shunt
responders prior to surgery were accompanied by elevated levels of ABP wave amplitudes or elevated CO. In the
individual patients the correlation between CO and ICP wave amplitude was partly related to an association
between ABP and ICP wave amplitudes which can be indicative of the state of cerebrovascular pressure regulation,
and partly related to the ICP wave amplitude which can be indicative of the intracranial compliance.
Background
The clinical condition idiopathic normal pressure hydroce-
phalus (iNPH) consists of unsteady gait, urinary inconti-
nence, dementia, and enlarged lateral ventricles [1]. The
preferred treatment is insertion of a shunt for drainage of
cerebrospinal fluid (CSF), which gives good clinical results
and a favourable complication profile [2,3]. Despite recent
advances in the treatment of iNPH, the rationale for treat-
ment is based on a limited understanding of its pathophy-
siology. Possible important pathophysiological mechanisms
include reduced regional/global cerebral blood flow (CBF)
indicative of chronic ischemia [4-8], impaired intracranial
compliance (ICC) [9-12], and impaired cerebral pulsation
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[13,14]. We have considered impaired ICC to be a crucial
pathophysiological mechanism behind iNPH [11,12], and
have previously reported that the ICC becomes reduced
when the amplitude of intracranial pressure (ICP) waves
increases [15].
In a previous study of 130 shunted iNPH patients, we had
significant clinical improvement in response to shunt treat-
ment in 9 out of 10 patients with high ICP wave amplitudes
(MWAICP; ≥4 mmHg on average and ≥5 mmHg in 10% of
recording time), but in only 1 of 10 patients with low ICP
wave amplitudes [11]. Given these promising results, it is
important to understand better the causes for elevated ICP
wave amplitudes in iNPH. In general, the ICP wave is
determined by many factors such as changes in cerebral
blood volume (CBV) during the cardiac cycle [16-18], and
possibly by alterations in cardiac output (CO) [19,20]. In
iNPH, vascular factors might be particularly important
since this condition is accompanied with a high incidence
of vascular co-morbidity such as hypertension, ischemic
heart disease and diabetes [5,21-26]. Obviously, vascular
disease might affect how the ABP waves that are created by
the cardiac contractions are transferred into the ICP waves.
From previous experimental work, it has been established
that during impaired cerebrovascular pressure regulation,
the ABP waves are transferred more passively to the ICP
waves [27-29]. Accordingly, we hypothesised that in iNPH
patients with vascular disease, increased ICP wave ampli-
tudes might be a reflection of increased ABP wave ampli-
tudes and possibly increased CO.
The present study was undertaken to investigate
whether CO is related to ABP and ICP wave amplitudes
and to shunt response in iNPH patients, in particular,
whether the increased ICP wave amplitudes seen in
iNPH patients that subsequently respond to shunt sur-
gery are accompanied by increased levels of CO or ABP
wave amplitudes.
Methods
Patients
The study included 29 consecutive patients evaluated for
clinical iNPH at the Department of Neurosurgery, Oslo
University Hospital - Rikshospitalet, as part of our stan-
dardized pre-operative evaluation of iNPH patients. One
additional patient was excluded from the study due to
technical problems with the ABP signal. The study was
approved by the Regional Ethical Committee of Health
Region South-East in Norway (S-07362b) and by Rik-
shospitalet (07/5870). Written informed consent was
obtained from the patients before the study inclusion.
Diagnostic work-up and follow-up after shunting
The patients were referred with suspected iNPH from
local neurological departments based on their clinical
symptoms and findings (gait disturbance, incontinence,
and dementia) combined with radiological ventriculome-
galy. Based on our findings at neurological examination,
the severity of clinical iNPH was graded using a NPH
grading scale ranging from a best score of 15 to a worst
score of 3 (see additional file 1, Table showing NPH
grading scale) which assesses the combined severity of
gait disturbance, urinary incontinence and dementia
[11]. The criteria for surgical treatment were based on
symptoms (NPH grading), increased ventricular size
(Evan’s index >0.3), and findings from the diagnostic
ICP monitoring. The surgical treatment was insertion of
a ventricular-peritoneal (VP) shunt with a HAKIM™
programmable valve shunt system (Codman & Shurtleff,
Inc. Le Locle, Switzerland), with an opening pressure at
implantation of 12 cm H2O.
Follow-up examination (NPH grading) was performed
in our out-patient clinic 12 months after surgery. We
defined an increase ≥2i nN P Hs c o r ea t1 2m o n t h sa s
representative of clinical improvement; the surgically
treated patients were categorized either as responders
(change in NPH score ≥2) or non-responders (change in
NPH score <2), respectively.
Monitoring and analysis of CO, ABP and ICP wave
amplitudes
The design of the study was to simultaneously monitor
CO, ABP, and ICP overnight using a computerized
recording system, as part of the diagnostic procedure
(above). The patients were kept supine in bed during
the entire recording.
Continuous monitoring of CO was performed with the
LiDCO™plus (software version 4.0, LiDCO Ltd.,
Cambridge, UK). This is a minimally invasive technique
incorporating two methods: a continuous arterial waveform
analysis system (PulseCO), coupled to a single-point lithium
indicator dilution calibration system (LiDCO) [30,31]. As
previously described [31], the calibration procedure involves
injection of 0.3 mmol lithium chloride through a peripheral
line. The lithium is detected by an external lithium ion-
sensitive external electrode connected to the peripheral
arterial line, which enables monitoring of the actual CO. In
all the present patients, monitoring of hemodynamic para-
meters was done after calibration. The primary measure for
this study was the CO, but the software also computed the
stroke volume (SV), heart rate (HR), oxygen consumption
(DO2), and systemic vascular resistance (SVR). ABP was
measured continuously in the right radial artery using the
Truwave PX-600F Pressure Monitoring Set (Edwards Life
sciences LLC, Irvine, CA, USA). The ABP sensor was
placed at the level of the heart. ICP was monitored continu-
ously using a solid sensor (Codman MicroSensor™,
Johnson & Johnson, Raynham, MA, USA), introduced 1-2
cm into the frontal brain parenchyma through a small burr
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described [11].
The continuous ABP and ICP waveforms were sampled
at 200 Hz, digitized using the Sensometrics
® Pressure
Logger (dPCom AS, Oslo, Norway) and analyzed using
Sensometrics
® software (dPCom AS). The LiDCO™plus
and Sensometrics
® software’s had identical time refer-
ence. An example of the simultaneous recordings is illu-
strated in Figure 1. Cardiac output retrieved from the
LiDCO™plus Hemodynamic Monitor was averaged over
6 - st i m ew i n d o w s( F i g u r e1 a ) .A sp r e v i o u s l yd e s c r i b e d
[32], the single ABP waves (Figure 1b) and ICP waves
Figure 1 Illustration of continuous monitoring in patient #5. Recordings of three consecutive 6-s time windows (time windows 364-366)
from a patient, showing (a) the averaged cardiac output (CO) over each 6-s time window, (b) the arterial blood pressure (ABP) signal, and
(c) the intracranial pressure (ICP) signal for the same time period. For each of the 6-s time windows the calculated CO, mean ABP wave
amplitude (MWAABP), and mean ICP wave amplitude (MWAICP) is presented in (d).
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being characterized by the amplitude, rise time, and rise
time coefficient. For each consecutive 6-s time window,
cardiac output, mean ABP wave amplitude and mean
ICP wave amplitude were computed, and exported to a
spread sheet program for further analysis (Figure 1d).
During the pre-operative work-up, the patients were
divided into two management groups: group A with ele-
vated ICP wave amplitudes (MWAICP) and group B with
low ICP wave amplitudes (Table 1), according to our
previously-established criteria for increased ICP wave
amplitudes during diagnostic ICP monitoring [11]. Thus
“elevated” ICP wave amplitudes were defined as: average
of mean ICP wave amplitude ≥4 mmHg, combined with
mean ICP wave amplitude ≥5m m H gi n≥ 10% of the
time recording during the period 23.00h - 07.00h [11].
Conversely, “low” ICP wave amplitudes were defined as:
average of mean ICP wave amplitude <4 mmHg, com-
bined with mean ICP wave amplitude ≥5 mmHg in
<10% of the time recording during the same period [11].
The primary comparison was to determine differences
in cardiac-, and ABP/ICP-derived parameters between
management groups A and B (Table 2). Secondarily, for
each patient recording the following Pearson correlation
coefficients were determined: (i) between CO and ABP
wave amplitude (CO/MWAABP correlation); (ii) between
CO vs. ICP wave amplitude (CO/MWAICP correlation);
and (iii) between ABP and ICP wave amplitude
(MWAABP/MWAICP correlation; Table 3).
The MWAABP/MWAICP correlation has been previously
introduced as a tentative indicator of the state of cerebro-
vascular pressure regulation [33,34]. In this study, the
overall MWAABP/MWAICP correlation for each recording
was computed, while in previous studies the moving
MWAABP/MWAICP correlation has been used [33,34].
Statistical analysis
Statistical analyses were performed in SPSS, version 12.0
(SPSS Inc., Chicago, IL, USA). Differences between man-
agement groups of continuous data were determined by
one-way ANOVA. Significant correlations between para-
meters of individual recordings were determined using
the Pearson correlation. Significance was accepted at the
0.05 level.
Results
Patients
Of the 29 patients in the study, 20 were in management
group A, and 9 in management group B. Shunting was
performed on 22 patients, 19/20 from group A and 3/9
from group B. Demographic, clinical, radiological and
management data of the two groups are shown in Table 1
and no significant differences were seen between groups.
The continuous monitoring of cardiac and pressure
data gave no complications or side-effects. Comparison
of the cardiac and arterial pressure data for groups A and
B revealed no significant differences between groups in
levels of CO or ABP wave amplitude (or other cardiac/
ABP parameters; Table 2). However, table 2 shows that
the CO/MWAICP correlation was significantly more
negative in group A than B. When considering all 29
recordings, there was no significant overall correlation
between average values of CO and ICP wave amplitude
(Pearson correlation coefficient 0.07, ns; data not shown).
Shunt response versus cardiac and pressure data
The clinical improvement 12 months after shunting
(that is, change in NPH score) related poorly to the CO
Table 1 Demographic, clinical, radiological and
management data of the two management groups
Management Groups
Group A
(elevated
MWAICP)
Group B (low
MWAICP)
Significance
Demographic
Patients (n) 20 (69%) 9 (31%)
Age (yrs) 76 (53 - 84) 78 (66 - 80) ns
Gender (F/M) 12/8 3/6 ns
BMI 24.3 (15.1 - 29.4) 24.0 (20.0 - 31.3) ns
Vascular
co-morbidity
Diabetes 5 (25%) 1 (11%) ns
Hypertension 3 (15%) 3 (33%) ns
Cardiovascular 8 (40%) 3 (33%) ns
Cerebrovascular 5 (25%) 2 (22%) ns
Cardiac
arrhythmia
3 (15%) 3 (33%) ns
Radiology
Evan’s index 0.37 (0.30 - 0.44) 0.38 (0.33 - 0.42) ns
Symptoms
Duration of
symptoms (yrs)
2.0 (0.4 - 10) 2.0 (0.8 - 6.0) ns
Preoperative NPH
score
10 (7 - 13) 10 (9 - 11) ns
Treatment
Conservative (n) 1 6
Shunt (n) 19 3
Outcome
Shunt Non-
responders
3 (16%) 3 (100%)
Shunt Responders 16 (84%) -
Management groups were defined according to published criteria [11]. BMI:
Body mass index. Significance: ns = non-significant; Fischer Exact test or one-
way ANOVA).
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ns), but it correlated highly significantly to the ICP wave
amplitude (Figure 2c; P = 0.003). Thus, with higher pre-
operative ICP wave amplitude levels, better clinical
improvement of iNPH symptoms was observed
12 months after shunting (Figure 2c).
While shunt response was related to the level of ICP
wave amplitudes, the response to shunting was less depen-
dent on the CO/MWAICP and MWAABP/MWAICP corre-
lation levels (Table 3). In particular, it should be noted
that clinical response to shunting was seen in patients
with high MWAICP levels (group A) even in the presence
of significant positive CO/MWAICP correlation or signifi-
cant positive MWAABP/MWAICP correlation. Among
the 7 shunted patients with significant positive CO/
MWAICP correlation, all the 4 shunt responders had
elevated MWAICP levels (group A) while the 3 shunt non-
responders had low MWAICP levels (group B). Moreover,
among the 14 shunted patients with significant positive
MWAABP/MWAICP correlation, all the 10 shunt respon-
ders had elevated MWAICP levels (group A); while 3 of 4
shunt non-responders had low MWAICP levels (group B).
The association between CO and ICP wave amplitudes
While a significant positive CO/MWAABP correlation
was seen in 28 of 29 patients (97%), significant positive
CO/MWAICP correlation was seen in only 10 of 29
patients (35%; Table 3). Most importantly, the patient
recordings with significant positive CO/MWAICP corre-
lation also presented with significant positive MWAABP/
MWAICP correlation (Table 4). When comparing the
data in Table 3 with significant MWAABP/MWAICP cor-
relations, the CO/MWAICP correlation values were sig-
nificantly more positive in the recordings with positive
than negative MWAABP/MWAICP correlation (respective
median values 0.07 versus -0.13; P = 0.001; ANOVA).
M o r e o v e r ,a ss h o w ni nT a b l e3 ,s i g n i f i c a n tn e g a t i v e
CO/MWAICP correlation (that is, CO declines when ICP
wave amplitude increases) was seen in 16 patients, 13
(81%) in group A and 3 (19%) in group B.
Discussion
This study for the first time reports an association
between CO and intracranial pressure dynamics in
hydrocephalus patients. One major observation was that
Table 2 Cardiac and pressure data for the two management groups
Management groups
Group A (elevated MWAICP) Group B (low MWAICP) Significance
Duration of recording
Accepted 6-s time windows 7,329 (1,022 - 12,388) 7,416 (3,370 - 9,143) ns
Cardiac parameters
CO (l/min) 5.6 (3.6 - 9.6) 5.5 (3.7 - 6.4) ns
SV (ml/beat) 81.1 (48.4 - 134.5) 82.1 (52.9 - 103.1) ns
HR (beats/min) 68.6 (58.8 - 89.7) 67.1 (62.3 - 87.9) ns
DO2 (ml ∙ min ∙ m
2)l) 1,006 (593 - 2,104) 923 (759 - 1,097) ns
SVR (dyne ∙ s∙ cm
5) 1,448 (508 - 2,157) 1,426 (997 - 2,144) ns
ABP parameters
Mean ABP (mmHg) 90.7 (72.5 - 112.3) 96.2 (78.0 - 108.1) ns
Mean ABP wave amplitude (MWAABP; mmHg) 68.6 (52.0 - 110.0) 60.9 (42.1 - 77.6) ns
ICP parameters
Mean ICP (mmHg) 6.4 (2.3 - 11.9) 4.7 (2.1 - 10.8) ns
Mean ICP wave amplitude (MWAICP; mmHg) 5.6 (4.0 - 10.2) 3.4 (2.8 - 4.0) c
Percentage mean ICP wave amplitude (MWAICP) ≥5 mmHg 68 (11 - 100) 2 (1 - 7) c
CPP
Mean CPP (mmHg) 87.2 (62.7 - 112.1) 92.9 (75.5 - 107.7) ns
Correlation values
CO/MWAABP 0.37 (0.02 - 0.80) 0.55 (0.09 - 0.87) ns
CO/MWAICP -0.06 (-0.24 - 0.21) 0.07 (-0.12 - 0.39) a
MWAABP/MWAICP 0.05 (-0.29 - 0.32) 0.09 (-0.15 - 0.35) ns
Management groups were defined according to published criteria [11]. Significance:
aP < 0.05;
cP < 0.001 (one-way ANOVA).
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the 29 patients were not accompanied with increased
levels of CO or ABP wave amplitude (Table 2).
Patient material
A l t h o u g ht h e r ew e r eo n l y2 9p a t i e n t s ,t h ed a t aa n a l y s i s
for each patient was based on a large number of obser-
vations; for each patient, recordings between 1,022 and
12,388 6-s time windows of good quality were available
for analysis (median 7,416 6-s time windows; Table 3).
The computerized recordings allowed comparisons of
CO, ABP and ICP wave amplitudes for concurrent 6-s
time windows (Figure 1). The methods for physiological
monitoring used in this study have previously been
described, including methods for ABP and ICP monitor-
ing [32], and the minimal invasive approach for CO
monitoring [30]. The PulseCO hemodynamic monitor
has been validated against the pulmonary artery catheter
method [35], and in various patient groups [36-41].
This cohort of 29 iNPH patients compared well with
our recently reported series of 130 surgically-treated
iNPH patients regarding age, gender, clinical severity,
and a rather high presence of vascular co-morbidity
[11]. As in the published series [11], the clinical
response to shunting was significantly correlated with
increasing levels of ICP wave amplitudes (Figure 2c). In
this department, demonstration of increased levels of
ICP wave amplitude during diagnostic overnight ICP
monitoring is used as an aid for management.
The ICP wave amplitude as an indicator of intracranial
compliance
During the last few years several studies have focused on
ap o s s i b l ei m p o r t a n tr o l eo fi m p a i r e dI C Cf o rt h ed e v e l -
opment of communicating hydrocephalus [9-12].
Table 3 Pearson product-moment correlation coefficients between different measured variables
Patient number Number of 6s recordings CO/MWAABP CO/MWAICP MWAABP/MWAICP Management group Outcome Category
1 3,370 0.55
c -0.11
c 0.09
c BC
2 12,388 0.54
c -0.12
c -0.22
c AN R
3 4,776 0.08
c 0.08
c 0.32
c AC
4 10,627 0.31
c 0.09
c 0.01 A R
5 6,562 0.66
c -0.18
c -0.22
c AR
6 7,627 0.52
c -0.24
c -0.29
c AR
7 6,081 0.25
c -0.18
c -0.14
c AR
8 8,501 0.87
c 0.23
c 0.23
c BN R
9 8,172 0.85
c 0.37
c 0.35
c BN R
10 1,022 0.25
c -0.003 0.14
c AR
11 10,715 0.63
c 0.18
c 0.26
c AR
12 4,519 0.60
c -0.08
c 0.003 B C
13 6,089 0.80
c -0.04
a 0.04
a AR
14 8,518 0.12
c -0.19
c 0.23
c AN R
15 8,202 0.59
c -0.03
a 0.05
c AR
16 7,030 0.14
c -0.05
c 0.21
c AR
17 3,538 0.25
c -0.12
c -0.15
c BC
18 8,239 0.58
c -0.07
c -0.07
c AR
19 7,416 0.44
c 0.005 0.18
c BC
20 8,117 0.04
c -0. 08
c 0.21
c AR
21 5,476 0.02 -0.17
c 0.18
c AR
22 8,991 0.09
c 0.39
c 0.07
c BC
23 6,441 0.42
c -0.12
c -0.07
c AR
24 9,478 0.15
c -0.02 0.04
c AR
25 9,143 0.29
c 0.07
c 0.24
c BN R
26 5,291 0.12
c -0.13
c -0.03
a AN R
27 6,409 0.73
c 0.21
c 0.23
c AR
28 6,467 0.61
c 0.11
c 0.06
c BC
29 8,311 0.57
c 0.15
c 0.10
c AR
Median 7,416 0.44 -0.04 0.07
Ranges 1,022 - 12,388 0.02 - 0.87 -0.24 - 0.39 -0.29 - 0.35
CO: mean cardiac output; MWAABP: mean arterial blood pressure wave amplitude; MWAICP: mean intracranial pressure wave amplitude. Significance:
aP < 0.05;
bP < 0.01;
cP < 0.001 (Pearson correlation coefficient for each individual patient recording). C: Conservative management; NR: Surgical Non-Responder; R:
Responder.
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that the ICP wave amplitude serves as an indicator of
ICC (i.e. the pressure-volume reserve capacity). Recent
data using magnetic resonance imaging (MRI) provide
evidence that the ICC capacity mostly depends on the
contribution of the intracranial compartment rather than
the intrathecal [43]. We have interpreted the reduction in
ICP wave amplitudes following CSF diversion by
extended lumbar drainage [8] or shunt implantation [44]
as indicative of improved ICC. Others have used the lum-
bar infusion test to predict how much the ICP wave
amplitudes are reduced following CSF diversion [45].
It is assumed that the ICP wave amplitude represents the
pressure response to the intracranial volume change during
the cardiac cycle; the net intracranial volume change dur-
ing the cardiac cycle is about 1 ml [46]. The ICP wave
depends on variations in CBV [16,17,47]. Therefore, one
criticism against considering the ICP wave amplitude as an
indicator of ICC has been that the CBV is an unknown
variable, and probably subject to intra- and inter-individual
variation. On the other hand, it can be questioned how
large an impact such variations in CBV might have on the
ICP waveform, given that the net volume change is rather
small, and probably ranging between 0.7 and 1.2 ml. Thus,
more recently the Cambridge group reported that the ICP
wave amplitude of NPH patients was less dependent on
alterations in arterial CBV [18].
In the present cohort, there were no differences
between the management groups concerning the cardiac
(CO, SV, HR and SVR), ABP (mean ABP, mean ABP
wave amplitude) or CPP (mean CPP) parameters
(Table 2). This study confirms previous observations
[34] that there is a non-significant tendency towards
higher ABP wave amplitudes in iNPH shunt responders
while mean ABP and mean CPP are similar in both the
responder/non-responder groups. This study extends
previous knowledge by showing that at the group level
cardiac measures were close to identical between
patients with high or low ICP wave amplitudes. How-
ever, although the primary comparison showed no dif-
ferences in absolute levels of cardiac and blood pressure
parameters between groups, the secondary correlation
analysis revealed an interesting observation.
Figure 2 Cardiac output (CO) arterial blood pressure (ABP) and
intracranial pressure (ICP) wave amplitudes plotted against
post-shunt changes in NPH score. The association between
change in NPH score 12 months after shunting and the pre-
operative overnight average measurements of (a) CO (Pearson
correlation coefficient 0.24; ns), (b) ABP wave amplitude (Pearson
correlation coefficient 0.21; ns), and (c) ICP wave amplitude (Pearson
correlation coefficient 0.61; P = 0.003) are presented for the 22
shunted iNPH patients.
Table 4 Distribution of recordings with both significant
CO/MWAICP correlation and significant MWAABP/MWAICP
correlation
MWAABP/MWAICP correlation
CO/MWAICP
correlation
Significant
positive
Significant
negative
Significance
a
Significant positive 9 0
Significant negative 7 8 P = 0.009
aSignificance of numbers within the matrix was assessed using Fisher’s Exact
test.
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cerebrovascular pressure regulation
How the ABP waves transfer into the ICP waves
depends on the state of cerebrovascular pressure regula-
tion. Previous work on the transfer of ABP waves into
ICP waves gave evidence that loss of vasomotor tone of
precapillary vessels (disrupted cerebral pressure auto-
regulation) changed the ABP-to-ICP transmission into a
passive and linear pressure transmission [27-29]. Such
disrupted cerebral pressure regulation would cause the
ABP waves to correlate positively with the ICP waves.
This is our rational for considering the MWAABP/
MWAICP correlation as an indicator of the state of cere-
brovascular pressure regulation. According to this con-
cept, when the cerebrovascular pressure auto-regulation
is disrupted, the correlation between ABP and ICP wave
amplitudes becomes positive. The method of computing
moving MWAABP/MWAICP correlations was first
applied to patients with head injury [33] and iNPH [34].
The association between CO and ICP wave amplitudes
It is suggested that the association between CO and ICP
wave amplitudes (CO/MWAICP correlation) depends on
the state of cerebrovascular pressure regulation (indi-
cated by the MWAABP/MWAICP correlation). During
disrupted cerebrovascular pressure auto-regulation, CO
w o u l dd i r e c t l ya f f e c tt h eI C Pw a v ea m p l i t u d el e v e l s
(causing the CO/MWAICP correlation to become posi-
tive and approach +1), as opposed to a situation of
intact cerebrovascular pressure auto-regulation when
CO would less likely affect the ICP wave amplitude
levels (causing the CO/MWAICP correlation to become
non-significant or negative approaching -1). In line with
this, in patients with a significant positive CO/MWAICP
correlation, the MWAABP/MWAICP correlation was also
significantly positive (Table 4).
It should be noted that a clinically-significant shunt
response was seen in patients with increased ICP wave
amplitudes even though the recordings were accompa-
nied by significant positive CO/MWAICP correlations or
significant positive MWAABP/MWAICP correlations.
This latter observation compares with recent reports of
no significant differences in MWAABP/MWAICP correla-
tions between iNPH patients with clinical response to
shunting (high ICP wave amplitudes) or no clinical
response (low ICP wave amplitudes) [34]. This author
finds it reasonable to speculate that when iNPH patients
present with both impaired intracranial compliance
(indicated by high ICP wave amplitudes) and impaired
cerebrovascular pressure regulation (indicated by posi-
tive MWAABP/MWAICP correlation), the response to
shunting is primarily determined by the improvement in
intracranial compliance following CSF diversion.
In this cohort, a significant negative correlation
between CO and ICP wave amplitude was seen in 16 of
29 patient recordings (55%); 13 of the 16 recordings
were in group A (high ICP wave amplitudes) showing
that in patients with high MWAICP, a negative associa-
tion between CO and MWAICP predominates. Based on
some information in the literature, it is tempting to
speculate that such a negative correlation between CO
and ICP wave amplitudes have relevance for the patho-
physiology of iNPH. Following induction of experimen-
tal hydrocephalus in dogs, the ICP wave amplitudes
increased (indicative of reduced intracranial compliance)
and the CO became reduced, causing a negative correla-
tion between CO and ICP wave amplitudes [20]. They
also observed a global reduction in CBF, as well as
reduction of blood flow in cardiac tissue and evidence
of congestive heart failure [20]. They suggested that the
reduced CBF seen in animals with experimental hydro-
cephalus was secondary to reduced CO. This is an inter-
esting hypothesis given the many studies showing
reduced global and/or regional CBF in iNPH [4-7].
Thus, if reduced CO reduces cerebral blood flow (CBF),
it is possible that the reduced CBF seen in iNPH is at
least partly heart-mediated. If so, iNPH can be consid-
ered a systemic disease involving cardiovascular altera-
tions. It should be noted, however, that the past
literature is somewhat inconsistent regarding the asso-
ciation between CO and CBF, and it depends on the
state of the cerebral auto-regulation [48-51].
Conclusions
While this overall dataset from iNPH patients gave no
evidence of increased CO or ABP wave amplitude levels
in patients with increased ICP wave amplitudes, analysis
of recordings from individual patients provide evidence
that an association between CO and ICP wave ampli-
tudes is partly related to the association between ABP
and ICP wave amplitudes (which can be indicative of
the state of cerebrovascular pressure regulation), and
partly related to the levels of ICP wave amplitude
(which can be indicative of the intracranial compliance).
In this cohort, shunt response was primarily related to
level of ICP wave amplitudes. Further research is needed
to clarify how CO associates with the intracranial pres-
sure dynamics in hydrocephalus patients.
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